Today's Updates

Q&A: Mucus Plugging, Multimorbidity, and GOLD 2027, With Gerard Criner, MD
Published Date: 19 Nov 2026

Q&A: Mucus Plugging, Multimorbidity, and GOLD 2027, With Gerard Criner, MD

Read More
RENEW: Blinded Interim Data Show FVC Trends With LTI-03 in IPF
Published Date: 19 Nov 2026

RENEW: Blinded Interim Data Show FVC Trends With LTI-03 in IPF

Read More
Anaphylaxis Reporting Varies Across Respiratory Biologics In FAERS
Published Date: 19 Nov 2026

Anaphylaxis Reporting Varies Across Respiratory Biologics In FAERS

Read More
Navigating a New Era of Neuromuscular Drug Development and Care at MDA 2027 Angela Lek, PhD, Isabella Ciccone, MPH
Published Date: 19 Nov 2026

Angela Lek, PhD, chief research officer at the Muscular Dystrophy Association, discussed how the 2027 MDA Clinical and Scientific Conference agenda reflects key themes in neuromuscular medicine.

Read More
Spectris Misses Primary End Point in Pivotal HOPE Trial for Alzheimer Disease Isabella Ciccone, MPH
Published Date: 19 Nov 2026

In the prespecified mild subgroup of HOPE, 40-Hz gamma sensory stimulation was associated with 56% slowing on the ADCS-ADL and 47% slowing on the CDR-SB vs sham at 12 months.

Read More
Full X-TOLE2 Data Detail Azetukalner's Dose-Dependent Profile in Focal Epilepsy Marco Meglio
Published Date: 19 Nov 2026

Peer-reviewed results from the phase 3 X-TOLE2 trial, published in JAMA Neurology, detail azetukalner's seizure reduction and dose-dependent adverse events in adults with focal epilepsy.

Read More
FDA Approves Adrabetadex as First Therapy Shown to Improve Survival in Infantile-Onset Niemann-Pick Disease Type C Isabella Ciccone, MPH
Published Date: 19 Nov 2026

The FDA approved Beren Therapeutics' adrabetadex, marketed as Lembaz, to reduce the risk of death in patients with infantile-onset Niemann-Pick disease type C.

Read More
AR1001 Slows Decline in Monotherapy Group of Phase 3 Alzheimer Trial Louie Pasculli
Published Date: 19 Nov 2026

Phase 3 POLARIS-AD results show AR1001 benefit on CDR-SB in a prespecified monotherapy population, but not in the overall early Alzheimer disease population.

Read More
NeuroVoices: Brian Lin, PhD, on the FDA Approval of Gefurulimab for Generalized Myasthenia Gravis Brian Lin, PhD, Isabella Ciccone, MPH
Published Date: 19 Nov 2026

The senior director of research at the Muscular Dystrophy Association discussed what the newly approved once-weekly C5 inhibitor adds to generalized myasthenia gravis care.

Read More
Orlando Forum Weighs Dual Antiplatelet Therapy Duration After Stroke David Z. Rose, MD, Isabella Ciccone, MPH
Published Date: 19 Nov 2026

At an HCPLive and NeurologyLive Clinical Forum in Orlando, David Z. Rose, MD, of USF Morsani College of Medicine, discussed residual recurrence risk, dual antiplatelet therapy duration, and factor XIa inhibition in noncardioembolic stroke.

Read More
What Drives Balcinrenone’s BP Effect? With Adriana Marton, MD Adriana Marton, MD
Published Date: 19 Nov 2026

Investigators will probe acid base metabolism and metabolomics to explain the blood pressure and potassium findings from DapaBalci-Leap.

Read More
INSAKA: Insulin Plus Salbutamol Tops Monotherapy for Hyperkalemia Emmanuel Montassier, MD, PhD
Published Date: 19 Nov 2026

Emmanuel Montassier presented potassium data at 60 minutes from 398 adults treated for acute hyperkalemia in the ED.

Read More
Tenapanor Linked to Lower IBS-C Care Use, With Kyle Staller, MD, MPH Kyle Staller, MD, MPH
Published Date: 19 Nov 2026

A real world analysis of 470 patients presented at ACG 2026 found median GI visits fell from 4.5 to 3.0 in the year after initiation

Read More
Tenapanor in Previously Treated IBS-C, With Kyle Staller, MD, MPH Kyle Staller, MD, MPH
Published Date: 19 Nov 2026

GI health care use still fell among patients who had already tried another IBS-C drug, per a real world ACG 2026 analysis.

Read More

Latest News


Latest News

News All Time


HTTP error: 503HTTP error: 503

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.

2.

We Don't Always Know What's 'Best' for Our Patients

3.

Year in Review: Multiple Myeloma

4.

UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms

5.

After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.



© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot